PRF Technologies (PRFX) Shares Outstanding (2019 - 2025)
PRF Technologies' (PRFX) quarterly Shares Outstanding (Entity) came in at $647973.0 in Q4 2025, up 614.34% YoY from $90709.0 in Q4 2024, and up 52.57% on a QoQ basis from $424708.0 in Q2 2025.
PRF Technologies (PRFX) Shares Outstanding (2019 - 2025) Analysis & Trends
PRF Technologies (PRFX) has 7 years of Shares Outstanding (Entity) data on file, last reported at $647973.0 in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 614.34% year-over-year to $647973.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $647973.0 (up 614.34% YoY) and the FY2025 annual result came in at $647973.0, up 614.34% from the prior year.
- Shares Outstanding (Entity) rose to $647973.0 in Q4 2025, from $424708.0 in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $647973.0 in Q4 2025 to a low of $7543.0 in Q1 2021.
- A 5-year average of $77694.9 and a median of $8934.0 in 2023 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) soared 1560.21% — and 2023, when it advanced 2.28%.
- Tracing PRFX's Shares Outstanding (Entity) over 5 years: stood at $8177.0 in 2021, then increased by 8.65% to $8884.0 in 2022, then climbed by 22.78% to $10908.0 in 2023, then jumped by 731.58% to $90709.0 in 2024, then jumped by 614.34% to $647973.0 in 2025.
- The last three Shares Outstanding (Entity) figures came in at $647973.0 (Q4 2025), $424708.0 (Q2 2025), and $90709.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 832.44 Mn |
| 10 | PRF Technologies | 647,973.00 | -3.49 Mn | - | 647,973.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 647,973.00 |
| Jun 30, 2025 | 424,708.00 |
| Dec 31, 2024 | 90,709.00 |
| Jun 30, 2024 | 34,285.00 |
| Mar 31, 2024 | 16,886.00 |
| Dec 31, 2023 | 10,908.00 |
| Sep 30, 2023 | 10,181.00 |
| Jun 30, 2023 | 9,087.00 |
| Mar 31, 2023 | 8,934.00 |
| Dec 31, 2022 | 8,884.00 |
| Sep 30, 2022 | 8,862.00 |
| Jun 30, 2022 | 8,862.00 |
| Mar 31, 2022 | 8,735.00 |
| Dec 31, 2021 | 8,177.00 |
| Sep 30, 2021 | 8,110.00 |
| Jun 30, 2021 | 7,969.00 |
| Mar 31, 2021 | 7,543.00 |
| Dec 31, 2020 | 2,703.00 |
| Sep 30, 2020 | 1,157.00 |
| Jun 30, 2020 | 480.00 |